Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker — Stella

Recruiting

Back to Ovarian Neoplasms trials

Trial locations(1 site)

Denmark

Department of Gynaecology and Obstetrics, Aarhus University Hospital, Aarhus

Key details

Sponsor

University of Aarhus

Collaborators

Aarhus University Hospital

Enrollment target

~300 participants

Started

July 2022

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Sex

Female only

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov